Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Amyloid blood biomarker detects Alzheimer's disease.

Nabers A, Perna L, Lange J, Mons U, Schartner J, Güldenhaupt J, Saum KU, Janelidze S, Holleczek B, Rujescu D, Hansson O, Gerwert K, Brenner H.

EMBO Mol Med. 2018 Apr 6. pii: e8763. doi: 10.15252/emmm.201708763. [Epub ahead of print]

2.

Updated analysis on polypharmacy and mortality from the ESTHER study.

Schöttker B, Muhlack DC, Hoppe LK, Holleczek B, Brenner H.

Eur J Clin Pharmacol. 2018 Apr 6. doi: 10.1007/s00228-018-2445-1. [Epub ahead of print] No abstract available.

PMID:
29623360
3.

Methylomic survival predictors, frailty, and mortality.

Zhang Y, Saum KU, Schöttker B, Holleczek B, Brenner H.

Aging (Albany NY). 2018 Mar 6;10(3):339-357. doi: 10.18632/aging.101392.

4.

Survival of patients with hepatobiliary tract and duodenal cancer sites in Germany and the United States in the early 21st century.

Pulte D, Weberpals J, Schröder CC, Emrich K, Holleczek B, Katalinic A, Luttmann S, Sirri E, Jansen L, Brenner H; GEKID Cancer Survival Working Group.

Int J Cancer. 2018 Feb 26. doi: 10.1002/ijc.31322. [Epub ahead of print]

PMID:
29479701
5.

Dietary patterns and risk of advanced colorectal neoplasms: A large population based screening study in Germany.

Erben V, Carr PR, Holleczek B, Stegmaier C, Hoffmeister M, Brenner H.

Prev Med. 2018 Feb 23;111:101-109. doi: 10.1016/j.ypmed.2018.02.025. [Epub ahead of print]

PMID:
29477967
6.

Stage of cancer diagnoses among migrants from the former Soviet Union in comparison to the German population - are diagnoses among migrants delayed?

Cho AB, Jaehn P, Holleczek B, Becher H, Winkler V.

BMC Public Health. 2018 Jan 17;18(1):148. doi: 10.1186/s12889-018-5046-0.

7.

Differences in incidence and survival of oral cavity and pharyngeal cancers between Germany and the United States depend on the HPV-association of the cancer site.

Jansen L, Buttmann-Schweiger N, Listl S, Ressing M, Holleczek B, Katalinic A, Luttmann S, Kraywinkel K, Brenner H; GEKID Cancer Survival Working Group.

Oral Oncol. 2018 Jan;76:8-15. doi: 10.1016/j.oraloncology.2017.11.015. Epub 2017 Nov 21.

PMID:
29290288
8.

FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer.

Flockerzi FA, Roggia C, Langer F, Holleczek B, Bohle RM.

Virchows Arch. 2017 Dec 21. doi: 10.1007/s00428-017-2282-0. [Epub ahead of print]

PMID:
29270870
9.

Burden of hip fracture using disability-adjusted life-years: a pooled analysis of prospective cohorts in the CHANCES consortium.

Papadimitriou N, Tsilidis KK, Orfanos P, Benetou V, Ntzani EE, Soerjomataram I, Künn-Nelen A, Pettersson-Kymmer U, Eriksson S, Brenner H, Schöttker B, Saum KU, Holleczek B, Grodstein FD, Feskanich D, Orsini N, Wolk A, Bellavia A, Wilsgaard T, Jørgensen L, Boffetta P, Trichopoulos D, Trichopoulou A.

Lancet Public Health. 2017 May;2(5):e239-e246. doi: 10.1016/S2468-2667(17)30046-4. Epub 2017 Apr 11.

10.

Body mass index and breast cancer survival: a Mendelian randomization analysis.

Guo Q, Burgess S, Turman C, Bolla MK, Wang Q, Lush M, Abraham J, Aittomäki K, Andrulis IL, Apicella C, Arndt V, Barrdahl M, Benitez J, Berg CD, Blomqvist C, Bojesen SE, Bonanni B, Brand JS, Brenner H, Broeks A, Burwinkel B, Caldas C, Campa D, Canzian F, Chang-Claude J, Chanock SJ, Chin SF, Couch FJ, Cox A, Cross SS, Cybulski C, Czene K, Darabi H, Devilee P, Diver WR, Dunning AM, Earl HM, Eccles DM, Ekici AB, Eriksson M, Evans DG, Fasching PA, Figueroa J, Flesch-Janys D, Flyger H, Gapstur SM, Gaudet MM, Giles GG, Glendon G, Grip M, Gronwald J, Haeberle L, Haiman CA, Hall P, Hamann U, Hankinson S, Hartikainen JM, Hein A, Hiller L, Hogervorst FB, Holleczek B, Hooning MJ, Hoover RN, Humphreys K, Hunter DJ, Hüsing A, Jakubowska A, Jukkola-Vuorinen A, Kaaks R, Kabisch M, Kataja V; kConFab/AOCS Investigators, Knight JA, Koppert LB, Kosma VM, Kristensen VN, Lambrechts D, Le Marchand L, Li J, Lindblom A, Lindström S, Lissowska J, Lubinski J, Machiela MJ, Mannermaa A, Manoukian S, Margolin S, Marme F, Martens JWM, McLean C, Menéndez P, Milne RL, Marie Mulligan A, Muranen TA, Nevanlinna H, Neven P, Nielsen SF, Nordestgaard BG, Olson JE, Perez JIA, Peterlongo P, Phillips KA, Poole CJ, Pylkäs K, Radice P, Rahman N, Rüdiger T, Rudolph A, Sawyer EJ, Schumacher F, Seibold P, Seynaeve C, Shah M, Smeets A, Southey MC, Tollenaar RAEM, Tomlinson I, Tsimiklis H, Ulmer HU, Vachon C, van den Ouweland AMW, Van't Veer LJ, Wildiers H, Willett W, Winqvist R, Zamora MP, Chenevix-Trench G, Dörk T, Easton DF, García-Closas M, Kraft P, Hopper JL, Zheng W, Schmidt MK, Pharoah PDP.

Int J Epidemiol. 2017 Dec 1;46(6):1814-1822. doi: 10.1093/ije/dyx131.

11.

Observed and expected mortality in the German skin cancer screening pilot project SCREEN.

Eisemann N, Waldmann A, Holleczek B, Katalinic A.

J Med Screen. 2017 Jan 1:969141317734003. doi: 10.1177/0969141317734003. [Epub ahead of print]

PMID:
29169295
12.

Response: Methods for second primary cancers evaluation have to be standardized.

Chen T, Brenner H, Fallah M, Jansen L, Castro FA, Geiss K, Holleczek B, Katalinic A, Luttmann S, Sundquist K, Ressing M, Xu L, Hemminki K; GEKID Cancer Survival Working Group.

Int J Cancer. 2018 Mar 15;142(6):1286-1287. doi: 10.1002/ijc.31151. Epub 2017 Nov 24. No abstract available.

PMID:
29134649
13.

Frailty and healthcare costs-longitudinal results of a prospective cohort study.

Hajek A, Bock JO, Saum KU, Matschinger H, Brenner H, Holleczek B, Haefeli WE, Heider D, König HH.

Age Ageing. 2018 Mar 1;47(2):233-241. doi: 10.1093/ageing/afx157.

PMID:
29036424
14.

No Association of Vitamin D Pathway Genetic Variants with Cancer Risks in a Population-Based Cohort of German Older Adults.

Ordóñez-Mena JM, Schöttker B, Saum KU, Holleczek B, Burwinkel B, Wang TJ, Brenner H.

Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1459-1461. doi: 10.1158/1055-9965.EPI-17-0191.

PMID:
28864453
15.

Risk of second primary cancers in women diagnosed with endometrial cancer in German and Swedish cancer registries.

Chen T, Brenner H, Fallah M, Jansen L, Castro FA, Geiss K, Holleczek B, Katalinic A, Luttmann S, Sundquist K, Ressing M, Xu L, Hemminki K; GEKID Cancer Survival Working Group+.

Int J Cancer. 2017 Dec 1;141(11):2270-2280. doi: 10.1002/ijc.30930. Epub 2017 Aug 29.

PMID:
28815572
16.

Survival for patients with rare haematologic malignancies: Changes in the early 21st century.

Pulte D, Weberpals J, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Brenner H; GEKID Cancer Survival Working Group.

Eur J Cancer. 2017 Oct;84:81-87. doi: 10.1016/j.ejca.2017.07.014. Epub 2017 Aug 8.

PMID:
28800491
17.

Vulvar cancer in Germany: increase in incidence and change in tumour biological characteristics from 1974 to 2013.

Holleczek B, Sehouli J, Barinoff J.

Acta Oncol. 2018 Mar;57(3):324-330. doi: 10.1080/0284186X.2017.1360513. Epub 2017 Aug 11.

PMID:
28799431
18.

In Reply.

Hoffmeister M, Holleczek B, Stock C, Brenner H.

Dtsch Arztebl Int. 2017 Jun 23;114(25):427. doi: 10.3238/arztebl.2017.0427. No abstract available.

19.

Toward a comprehensive cancer registration in Germany.

Holleczek B, Katalinic A.

Eur J Cancer Prev. 2017 Sep;26 Joining forces for better cancer registration in Europe:S132-S138. doi: 10.1097/CEJ.0000000000000388.

PMID:
28639952
20.

Complication Rates in Colonoscopy Screening for Cancer.

Zwink N, Holleczek B, Stegmaier C, Hoffmeister M, Brenner H.

Dtsch Arztebl Int. 2017 May 5;114(18):321-327. doi: 10.3238/arztebl.2017.0321.

21.

Polypharmacy and mortality: new insights from a large cohort of older adults by detection of effect modification by multi-morbidity and comprehensive correction of confounding by indication.

Schöttker B, Saum KU, Muhlack DC, Hoppe LK, Holleczek B, Brenner H.

Eur J Clin Pharmacol. 2017 Aug;73(8):1041-1048. doi: 10.1007/s00228-017-2266-7. Epub 2017 May 24.

PMID:
28540438
22.

Vitamin D Supplementation Trials Aimed at Reducing Mortality Have Much Higher Power When Focusing on People with Low Serum 25-Hydroxyvitamin D Concentrations.

Brenner H, Jansen L, Saum KU, Holleczek B, Schöttker B.

J Nutr. 2017 Jul;147(7):1325-1333. doi: 10.3945/jn.117.250191. Epub 2017 May 24.

PMID:
28539415
23.

Incidence, Mortality, and Trends of Nonmelanoma Skin Cancer in Germany.

Leiter U, Keim U, Eigentler T, Katalinic A, Holleczek B, Martus P, Garbe C.

J Invest Dermatol. 2017 Sep;137(9):1860-1867. doi: 10.1016/j.jid.2017.04.020. Epub 2017 May 6.

PMID:
28487088
24.

Meat intake and risk of colorectal polyps: results from a large population-based screening study in Germany.

Carr PR, Holleczek B, Stegmaier C, Brenner H, Hoffmeister M.

Am J Clin Nutr. 2017 Jun;105(6):1453-1461. doi: 10.3945/ajcn.116.148304. Epub 2017 May 3.

PMID:
28468894
25.

Time trends of cause-specific mortality among resettlers in Germany, 1990 through 2009.

Kaucher S, Leier V, Deckert A, Holleczek B, Meisinger C, Winkler V, Becher H.

Eur J Epidemiol. 2017 Apr;32(4):289-298. doi: 10.1007/s10654-017-0240-4. Epub 2017 Mar 17.

PMID:
28314982
26.

DNA methylation signatures in peripheral blood strongly predict all-cause mortality.

Zhang Y, Wilson R, Heiss J, Breitling LP, Saum KU, Schöttker B, Holleczek B, Waldenberger M, Peters A, Brenner H.

Nat Commun. 2017 Mar 17;8:14617. doi: 10.1038/ncomms14617.

27.

Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21st century.

Weberpals J, Pulte D, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Merz M, Brenner H; GEKID Cancer Survival Working Group.

Haematologica. 2017 Jun;102(6):e229-e232. doi: 10.3324/haematol.2016.157768. Epub 2017 Mar 9. No abstract available.

28.

Screening for Bowel Cancer: Increasing Participation via Personal Invitation.

Hoffmeister M, Holleczek B, Zwink N, Stock C, Stegmaier C, Brenner H.

Dtsch Arztebl Int. 2017 Feb 10;114(6):87-93. doi: 10.3238/arztebl.2017.0087.

29.

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.

Fagerholm R, Khan S, Schmidt MK, García-Closas M, Heikkilä P, Saarela J, Beesley J, Jamshidi M, Aittomäki K, Liu J, Ali HR, Andrulis IL, Beckmann MW, Behrens S, Blows FM, Brenner H, Chang-Claude J, Couch FJ, Czene K, Fasching PA, Figueroa J, Floris G, Glendon G, Guo Q, Hall P, Hallberg E, Hamann U, Holleczek B, Hooning MJ, Hopper JL, Jager A, Kabisch M; kConFab/AOCS Investigators, Keeman R, Kosma VM, Lambrechts D, Lindblom A, Mannermaa A, Margolin S, Provenzano E, Shah M, Southey MC, Dennis J, Lush M, Michailidou K, Wang Q, Bolla MK, Dunning AM, Easton DF, Pharoah PD, Chenevix-Trench G, Blomqvist C, Nevanlinna H.

Oncotarget. 2017 Mar 14;8(11):18381-18398. doi: 10.18632/oncotarget.15110.

30.

Incidence of lip malignancies in Germany-data from nine population-based cancer registries.

Singer S, Zeissig SR, Emrich K, Holleczek B, Kraywinkel K, Ressing M.

J Oral Pathol Med. 2017 Oct;46(9):780-785. doi: 10.1111/jop.12559. Epub 2017 Mar 2.

PMID:
28178758
31.

Quality of life in long-term and very long-term cancer survivors versus population controls in Germany.

Arndt V, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H.

Acta Oncol. 2017 Feb;56(2):190-197. doi: 10.1080/0284186X.2016.1266089. Epub 2017 Jan 5.

PMID:
28055266
32.

Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort Study.

Saum KU, Schöttker B, Meid AD, Holleczek B, Haefeli WE, Hauer K, Brenner H.

J Am Geriatr Soc. 2017 Feb;65(2):e27-e32. doi: 10.1111/jgs.14718. Epub 2016 Dec 26.

PMID:
28024089
33.

Smoking-associated DNA methylation markers predict lung cancer incidence.

Zhang Y, Elgizouli M, Schöttker B, Holleczek B, Nieters A, Brenner H.

Clin Epigenetics. 2016 Nov 25;8:127. doi: 10.1186/s13148-016-0292-4. eCollection 2016.

34.

Genetic Variants in the Vitamin D Pathway, 25(OH)D Levels, and Mortality in a Large Population-Based Cohort Study.

Ordóñez-Mena JM, Maalmi H, Schöttker B, Saum KU, Holleczek B, Wang TJ, Burwinkel B, Brenner H.

J Clin Endocrinol Metab. 2017 Feb 1;102(2):470-477. doi: 10.1210/jc.2016-2468.

PMID:
27732326
35.

Pneumonia in the Noninstitutionalized Older Population.

Breitling LP, Saum KU, Schöttker B, Holleczek B, Herth FJ, Brenner H.

Dtsch Arztebl Int. 2016 Sep 16;113(37):607-614. doi: 10.3238/arztebl.2016.0607.

36.

In Reply.

Brenner H, Schrotz-King P, Hoffmeister M, Holleczek B, Katalinic A.

Dtsch Arztebl Int. 2016 Jul 25;113(29-30):507-8. doi: 10.3238/arztebl.2016.0507b. No abstract available.

37.

Comparison and combination of blood DNA methylation at smoking-associated genes and at lung cancer-related genes in prediction of lung cancer mortality.

Zhang Y, Breitling LP, Balavarca Y, Holleczek B, Schöttker B, Brenner H.

Int J Cancer. 2016 Dec 1;139(11):2482-92. doi: 10.1002/ijc.30374. Epub 2016 Aug 22.

38.

Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort.

Perna L, Zhang Y, Mons U, Holleczek B, Saum KU, Brenner H.

Clin Epigenetics. 2016 Jun 3;8:64. doi: 10.1186/s13148-016-0228-z. eCollection 2016.

39.

Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?

Winter A, Sirri E, Jansen L, Wawroschek F, Kieschke J, Castro FA, Krilaviciute A, Holleczek B, Emrich K, Waldmann A, Brenner H; Association of Population-based Cancer Registries in Germany (GEKID) Cancer Survival Working Group.

BJU Int. 2017 Apr;119(4):550-559. doi: 10.1111/bju.13537. Epub 2016 Jun 20.

40.

Histologic types of gastric cancer among migrants from the former Soviet Union and the general population in Germany: what kind of prevention do we need?

Jaehn P, Holleczek B, Becher H, Winkler V.

Eur J Gastroenterol Hepatol. 2016 Aug;28(8):863-70. doi: 10.1097/MEG.0000000000000645.

PMID:
27187801
41.

Survival of elderly patients with multiple myeloma-Effect of upfront autologous stem cell transplantation.

Merz M, Jansen L, Castro FA, Hillengass J, Salwender H, Weisel K, Scheid C, Luttmann S, Emrich K, Holleczek B, Katalinic A, Nennecke A, Straka C, Langer C, Engelhardt M, Einsele H, Kröger N, Beelen D, Dreger P, Brenner H, Goldschmidt H; GEKID Cancer Survival Working Group and the DRST.

Eur J Cancer. 2016 Jul;62:1-8. doi: 10.1016/j.ejca.2016.04.004. Epub 2016 May 10.

PMID:
27185572
42.

Survival in patients with acute myeloblastic leukemia in Germany and the United States: Major differences in survival in young adults.

Pulte D, Jansen L, Castro FA, Krilaviciute A, Katalinic A, Barnes B, Ressing M, Holleczek B, Luttmann S, Brenner H; GEKID Cancer Survival Working Group.

Int J Cancer. 2016 Sep 15;139(6):1289-96. doi: 10.1002/ijc.30186. Epub 2016 May 31.

43.

Fear of recurrence in long-term cancer survivors-Do cancer type, sex, time since diagnosis, and social support matter?

Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V.

Health Psychol. 2016 Dec;35(12):1329-1333. doi: 10.1037/hea0000374. Epub 2016 May 12.

PMID:
27175578
44.

Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer.

Werner S, Chen H, Butt J, Michel A, Knebel P, Holleczek B, Zörnig I, Eichmüller SB, Jäger D, Pawlita M, Waterboer T, Brenner H.

Sci Rep. 2016 May 3;6:25467. doi: 10.1038/srep25467.

45.

Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century.

Pulte D, Castro FA, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Brenner H; GEKID Cancer Survival Working Group.

J Hematol Oncol. 2016 Mar 22;9:28. doi: 10.1186/s13045-016-0257-2.

46.

Association of helicobacter pylori infection and chronic atrophic gastritis with risk of colonic, pancreatic and gastric cancer: A ten-year follow-up of the ESTHER cohort study.

Chen XZ, Schöttker B, Castro FA, Chen H, Zhang Y, Holleczek B, Brenner H.

Oncotarget. 2016 Mar 29;7(13):17182-93. doi: 10.18632/oncotarget.7946.

47.

Declining Bowel Cancer Incidence and Mortality in Germany.

Brenner H, Schrotz-King P, Holleczek B, Katalinic A, Hoffmeister M.

Dtsch Arztebl Int. 2016 Feb 19;113(7):101-6. doi: 10.3238/arztebl.2016.0101. Review.

48.

Frailty is associated with the epigenetic clock but not with telomere length in a German cohort.

Breitling LP, Saum KU, Perna L, Schöttker B, Holleczek B, Brenner H.

Clin Epigenetics. 2016 Feb 26;8:21. doi: 10.1186/s13148-016-0186-5. eCollection 2016.

49.

Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries.

Chen T, Fallah M, Brenner H, Jansen L, Mai EK, Castro FA, Katalinic A, Emrich K, Holleczek B, Geiss K, Eberle A, Sundquist K, Hemminki K; GEKID Cancer Survival Working Group.

Sci Rep. 2016 Feb 24;6:22084. doi: 10.1038/srep22084.

50.

Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States.

Sirri E, Castro FA, Kieschke J, Jansen L, Emrich K, Gondos A, Holleczek B, Katalinic A, Urbschat I, Vohmann C, Brenner H.

Pancreas. 2016 Jul;45(6):908-14. doi: 10.1097/MPA.0000000000000588.

PMID:
26745860

Supplemental Content

Loading ...
Support Center